Predictive Model for at Home Care Among Patients With Solid-Tumor Malignancies
Researchers developed a predictive model for identifying admissions of patients with cancer who were potentially suitable for in-patient level care at home, or hospital at home
Clinician- vs Patient-Reported Performance Status for Predicting Patient Outcomes
Study results show both clinician- and patient-reported performance status are useful for predicting morbidity and mortality in patients with advanced cancer receiving chemotherapy.
Variation in Treatment Planning of Radiation Therapy Procedures in the United States
Study suggests provider characteristics, like gender and geographic region may play a role in predicting treatment planning of radiation oncology procedures.
FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Gastric Cancer
The FDA granted approval to fam-trastuzumab deruxtecan-nxki for adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal adenocarcinoma.
Cost-Sharing Patterns for PARP Inhibitor Therapy in Ovarian Cancer
Results from a single-center study show payers incur the bulk of monthly PARP inhibitor cost for ovarian cancer.